G protein-Coupled estrogen receptor-1 is involved in the protective effect of protocatechuic aldehyde against endothelial dysfunction

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Kong, Byung S ^a   Cho, Yoon H ^a   Lee, Eun J ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR 30; HYDROGEN PEROXIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTOCATECHUALDEHYDE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; 1,3 BENZODIOXOLE DERIVATIVE; 4-(6-BROMO-1,3-BENZODIOXOL-5-YL)-3A,4,5,9B-3H-CYCLOPENTA(C)QUINOLINE; BENZALDEHYDE DERIVATIVE; CATECHOL DERIVATIVE; G PROTEIN COUPLED RECEPTOR; GPR30 PROTEIN, MOUSE; QUINOLINE DERIVATIVE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; DISEASE MARKER; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; EPITHELIZATION; EXPLANT; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; MALE; NEOINTIMA; NONHUMAN; PROTEIN EXPRESSION; RAT; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM; VASCULAR RING; ANIMAL; CAROTID ARTERY INJURIES; DISEASE MODEL; DRUG EFFECTS; METABOLISM; ORGAN CULTURE TECHNIQUE; PATHOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; THORACIC AORTA;

ANIMALS; AORTA, THORACIC; BENZALDEHYDES; BENZODIOXOLES; CAROTID ARTERY INJURIES; CATECHOLS; CYCLIC AMP; DISEASE MODELS, ANIMAL; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HYDROGEN PEROXIDE; MALE; NEOINTIMA; ORGAN CULTURE TECHNIQUES; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84913536715     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113242     Document Type: Article

References (33)

1. Chen J, Zhang J, Xu L, Xu C, Chen S, et al. (2012) Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor. Atherosclerosis 224: 332-339.
2. Gupta P, Goldenberg DM, Rossi EA, Cardillo TM, Byrd JC, et al. (2012) Dualtargeting immunotherapy of lymphoma: potent cytotoxicity of anti-CD20/ CD74 bispecific antibodies in mantle cell and other lymphomas. Blood 119: 3767-3778.
3. Baker M, Robinson SD, Lechertier T, Barber PR, Tavora B, et al. (2012) Use of the mouse aortic ring assay to study angiogenesis. Nat Protoc 7: 89-104.
4. Jeong JY, Lee DH, Kang SS (2013) Effects of chronic restraint stress on body weight, food intake, and hypothalamic gene expressions in mice. Endocrinol Metab (Seoul) 28: 288-296.
5. Nam YJ, Kim BH, Lee SK, Jeon YK, Kim SS, et al. (2013) Co-occurrence of papillary thyroid carcinoma and mucosa-associated lymphoid tissue lymphoma in a patient with long-standing hashimoto thyroiditis. Endocrinol Metab (Seoul) 28: 341-345.
6. Rodriguez-Calvo R, Guadall A, Calvayrac O, Navarro MA, Alonso J, et al. (2013) Over-expression of neuron-derived orphan receptor-1 (NOR-1) exacerbates neointimal hyperplasia after vascular injury. Hum Mol Genet 22: 1949- 1959.
7. Endemann DH, Schiffrin EL (2004) Endothelial dysfunction. J Am Soc Nephrol 15: 1983-1992.
8. Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, et al. (2005) Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: A statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens 23: 7-17.
9. Szmitko PE, Wang CH, Weisel RD, de Almeida JR, Anderson TJ, et al. (2003) New markers of inflammation and endothelial cell activation: Part I. Circulation 108: 1917-1923.
10. Uemura S, Matsushita H, Li W, Glassford AJ, Asagami T, et al. (2001) Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ Res 88: 1291-1298.
11. Khan BV, Harrison DG, Olbrych MT, Alexander RW, Medford RM (1996) Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci U S A 93: 9114-9119.
12. Nilsson BO, Olde B, Leeb-Lundberg LM (2011) G protein-coupled oestrogen receptor 1 (GPER1)/GPR30: A new player in cardiovascular and metabolic oestrogenic signalling. Br J Pharmacol 163: 1131-1139.
13. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER (2005) A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307: 1625-1630.
14. Mercier I, Mader S, Calderone A (2003) Tamoxifen and ICI 182,780 negatively influenced cardiac cell growth via an estrogen receptor-independent mechanism. Cardiovasc Res 59: 883-892.
15. Haas E, Bhattacharya I, Brailoiu E, Damjanovic M, Brailoiu GC, et al. (2009) Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ Res 104: 288-291.
16. Wei M, Chu X, Jiang L, Yang X, Cai Q, et al. (2012) Protocatechuic acid attenuates lipolysaccharide-induced acute lung injury. Inflammation 35: 1169-1178.
17. Moon CY, Ku CR, Cho YH, Lee EJ (2012) Protocatechuic aldehyde inhibits migration and proliferation of vascular smooth muscle cells and intravascular thrombosis. Biochem Biophys Res Commun 423: 116-121.
18. Kawabe-Yako R, Ii M, Masuo O, Asahara T, Itakura T (2011) Cilostazol activates function of bone marrow-derived endothelial progenitor cell for reendothelialization in a carotid balloon injury model. PLoS One 6: e24646.
19. Cho YH, Ku CR, Hong ZY, Heo JH, Kim EH, et al. (2013) Therapeutic effects of water soluble danshen extracts on atherosclerosis. Evid Based Complement Alternat Med 2013: 623639.
20. Kuriyama I, Nakajima Y, Nishida H, Konishi T, Takeuchi T, et al. (2013) Inhibitory effects of low molecular weight polyphenolics from Inonotus obliquus on human DNA topoisomerase activity and cancer cell proliferation. Mol Med Rep 8: 535-542.
21. Wei G, Guan Y, Yin Y, Duan J, Zhou D, et al. (2013) Anti-inflammatory effect of protocatechuic aldehyde on myocardial ischemia/reperfusion injury in vivo and in vitro. Inflammation 36: 592-602.
22. Chakrabarti S, Davidge ST (2012) G-protein coupled receptor 30 (GPR30): A novel regulator of endothelial inflammation. PLoS One 7: e52357.
23. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, et al. (2008) NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453: 807-811.
24. Hollenbaugh D, Mischel-Petty N, Edwards CP, Simon JC, Denfeld RW, et al. (1995) Expression of functional CD40 by vascular endothelial cells. J Exp Med 182: 33-40.
25. Geraldes P, Gagnon S, Hadjadj S, Merhi Y, Sirois MG, et al. (2006) Estradiol blocks the induction of CD40 and CD40L expression on endothelial cells and prevents neutrophil adhesion: An ERalpha-mediated pathway. Cardiovasc Res 71: 566-573.
26. Potthoff SA, Fahling M, Clasen T, Mende S, Ishak B, et al. (2014) Angiotensin- (1-7) modulates renal vascular resistance through inhibition of p38 mitogenactivated protein kinase in apolipoprotein E-deficient mice. Hypertension 63: 265-272.
27. Kohout TA, Lefkowitz RJ (2003) Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization. Mol Pharmacol 63: 9-18.
28. Benovic JL, Kuhn H, Weyand I, Codina J, Caron MG, et al. (1987) Functional desensitization of the isolated beta-adrenergic receptor by the beta-adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48-kDa protein). Proc Natl Acad Sci U S A 84: 8879-8882.
29. Milia AF, Salis MB, Stacca T, Pinna A, Madeddu P, et al. (2002) Proteaseactivated receptor-2 stimulates angiogenesis and accelerates hemodynamic recovery in a mouse model of hindlimb ischemia. Circ Res 91: 346-352.
30. Zucchetti AE, Barosso IR, Boaglio AC, Basiglio CL, Miszczuk G, et al. (2014) Gprotein- coupled receptor 30/adenylyl cyclase/protein kinase A pathway is involved in estradiol 17ss-d-glucuronide-induced cholestasis. Hepatology 59: 1016-1029.
31. Koganti S, Snyder R, Gumaste U, Karamyan VT, Thekkumkara T (2014) 2- methoxyestradiol binding of GPR30 down-regulates angiotensin AT(1) receptor. Eur J Pharmacol 723: 131-140.
32. O9Brien PJ, Siraki AG, Shangari N (2005) Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health. Crit Rev Toxicol 35: 609-662.
33. Hamza A, Sarma MH, Sarma RH (2003) Plausible interaction of an alphafetoprotein cyclopeptide with the G-protein-coupled receptor model GPR30: docking study by molecular dynamics simulated annealing. J Biomol Struct Dyn 20: 751-758.